Delcath Systems (DCTH) Reports Q3 Loss of $0.12/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Delcath Systems (DCTH) Reports Q3 Loss of $0.12/Share

Delcath Reports 2015 Third Quarter Financial Results

November 10, 2015 8:30 AM EST

NEW YORK, Nov. 10, 2015 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and nine months ended September 30, 2015. 

Financial and other highlights for the third quarter of 2015 and recent weeks included:

84% increase in total revenue compared with the third quarter of 2014 23% decrease in total operating expenses compared with the third quarter of 2014 Establishment of national reimbursement coverage for CHEMOSAT®... More